Canada Markets closed

Theralase Technologies Inc. (TLT.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.3300-0.0150 (-4.35%)
At close: 03:50PM EST
Full screen
Previous Close0.3450
Bid0.3300 x 0
Ask0.3400 x 0
Day's Range0.3250 - 0.3450
52 Week Range0.1700 - 0.3800
Avg. Volume272,081
Market Cap67.411M
Beta (5Y Monthly)1.88
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateNov. 25, 2021 - Nov. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Theralase Expands Intellectual Property Portfolio

    TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDCs”) and their associated drug formulations, used to destroy various cancers, bacteria and viruses, safely and effectively, is pleased to announce that the Company has expanded its Intellectual Property (“IP”) portfolio. Theralase® has recen

  • Baystreet

    Theralase, Tricon, Trevali, Uni-Select at 52-Week Highs

    Theralase Technologies Inc. (V.TLT) hit a new 52-week high of 36 cents on Monday. No news stories available ...

  • Baystreet

    Frontier, Reko, Therelase at 52-Week Highs

    Frontier Lithium Inc. (V: FL) hit a new 52-week high of $2.02 on Friday. No news stories available today. ...